Revolution Medicines, Inc. (RVMD) Operating margin 2018–2023
Revolution Medicines, Inc. (RVMD) operating margin by fiscal year — reported operating income divided by reported revenue.
-4207.1%FY2023 · since FY2018: -200.0% → -4207.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -4207.1% | -3477.1 pp |
| FY2022 | -730.0% | -90.3 pp |
| FY2021 | -639.7% | -382.2 pp |
| FY2020 | -257.5% | -149.4 pp |
| FY2019 | -108.2% | +91.8 pp |
| FY2018 | -200.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice